Literature DB >> 30415952

MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.

Manpreet Kalkat1, Diana Resetca1, Corey Lourenco1, Pak-Kei Chan2, Yong Wei3, Yu-Jia Shiah4, Natasha Vitkin2, Yufeng Tong5, Maria Sunnerhagen6, Susan J Done1, Paul C Boutros7, Brian Raught8, Linda Z Penn9.   

Abstract

Transforming members of the MYC family (MYC, MYCL1, and MYCN) encode transcription factors containing six highly conserved regions, termed MYC homology boxes (MBs). By conducting proteomic profiling of the MB interactomes, we demonstrate that half of the MYC interactors require one or more MBs for binding. Comprehensive phenotypic analyses reveal that two MBs, MB0 and MBII, are universally required for transformation. MBII mediates interactions with acetyltransferase-containing complexes, enabling histone acetylation, and is essential for MYC-dependent tumor initiation. By contrast, MB0 mediates interactions with transcription elongation factors via direct binding to the general transcription factor TFIIF. MB0 is dispensable for tumor initiation but is a major accelerator of tumor growth. Notably, the full transforming activity of MYC can be restored by co-expression of the non-transforming MB0 and MBII deletion proteins, indicating that these two regions confer separate molecular functions, both of which are required for oncogenic MYC activity.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BioID; MYC; TFIIF; TRRAP; cancer; histone acetylation; mass spectrometry; protein interactions; transcriptional elongation; transformation

Mesh:

Substances:

Year:  2018        PMID: 30415952     DOI: 10.1016/j.molcel.2018.09.031

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  45 in total

Review 1.  Target gene-independent functions of MYC oncoproteins.

Authors:  Apoorva Baluapuri; Elmar Wolf; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2020-02-18       Impact factor: 94.444

2.  Identifying and Validating MYC:Protein Interactors in Pursuit of Novel Anti-MYC Therapies.

Authors:  Diana Resetca; Alannah S MacDonald; Tristan M G Kenney; Yong Wei; Cheryl H Arrowsmith; Brian Raught; Linda Z Penn
Journal:  Methods Mol Biol       Date:  2021

3.  Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.

Authors:  Jonas Ecker; Venu Thatikonda; Gianluca Sigismondo; Florian Selt; Gintvile Valinciute; Ina Oehme; Carina Müller; Juliane L Buhl; Johannes Ridinger; Diren Usta; Nan Qin; Cornelis M van Tilburg; Christel Herold-Mende; Marc Remke; Felix Sahm; Frank Westermann; Marcel Kool; Robert J Wechsler-Reya; Lukas Chavez; Jeroen Krijgsveld; Natalie Jäger; Stefan M Pfister; Olaf Witt; Till Milde
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

4.  Depletion of TRRAP Induces p53-Independent Senescence in Liver Cancer by Down-Regulating Mitotic Genes.

Authors:  Suet-Yan Kwan; Ankur Sheel; Chun-Qing Song; Xiao-Ou Zhang; Tingting Jiang; Hien Dang; Yueying Cao; Deniz M Ozata; Haiwei Mou; Hao Yin; Zhiping Weng; Xin Wei Wang; Wen Xue
Journal:  Hepatology       Date:  2019-08-11       Impact factor: 17.425

5.  Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5-MYC Protein-Protein Interaction.

Authors:  Jonathan D Macdonald; Selena Chacón Simon; Changho Han; Feng Wang; J Grace Shaw; Jennifer E Howes; Jiqing Sai; Joannes P Yuh; Demarco Camper; Bethany M Alicie; Joseph Alvarado; Sameer Nikhar; William Payne; Erin R Aho; Joshua A Bauer; Bin Zhao; Jason Phan; Lance R Thomas; Olivia W Rossanese; William P Tansey; Alex G Waterson; Shaun R Stauffer; Stephen W Fesik
Journal:  J Med Chem       Date:  2019-12-05       Impact factor: 7.446

6.  Localized Inhibition of Protein Phosphatase 1 by NUAK1 Promotes Spliceosome Activity and Reveals a MYC-Sensitive Feedback Control of Transcription.

Authors:  Giacomo Cossa; Isabelle Roeschert; Florian Prinz; Apoorva Baluapuri; Raphael Silveira Vidal; Christina Schülein-Völk; Yun-Chien Chang; Carsten Patrick Ade; Guido Mastrobuoni; Cyrille Girard; Lars Wortmann; Susanne Walz; Reinhard Lührmann; Stefan Kempa; Bernhard Kuster; Elmar Wolf; Dominik Mumberg; Martin Eilers
Journal:  Mol Cell       Date:  2020-01-31       Impact factor: 17.970

Review 7.  Monitoring protein communities and their responses to therapeutics.

Authors:  Hanna G Budayeva; Donald S Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2020-03-05       Impact factor: 84.694

Review 8.  MYC protein interactors in gene transcription and cancer.

Authors:  Diana Resetca; Cornelia Redel; Corey Lourenco; Peter Lin; Alannah S MacDonald; Roberto Ciaccio; Tristan M G Kenney; Yong Wei; David W Andrews; Maria Sunnerhagen; Cheryl H Arrowsmith; Brian Raught; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2021-06-29       Impact factor: 60.716

9.  Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy.

Authors:  Huiying Han; Atul D Jain; Mihai I Truica; Javier Izquierdo-Ferrer; Jonathan F Anker; Barbara Lysy; Vinay Sagar; Yi Luan; Zachary R Chalmers; Kenji Unno; Hanlin Mok; Rajita Vatapalli; Young A Yoo; Yara Rodriguez; Irawati Kandela; J Brandon Parker; Debabrata Chakravarti; Rama K Mishra; Gary E Schiltz; Sarki A Abdulkadir
Journal:  Cancer Cell       Date:  2019-10-31       Impact factor: 31.743

10.  Multiple direct interactions of TBP with the MYC oncoprotein.

Authors:  Yong Wei; Diana Resetca; Zhe Li; Isak Johansson-Åkhe; Alexandra Ahlner; Sara Helander; Amelie Wallenhammar; Vivian Morad; Brian Raught; Björn Wallner; Tetsuro Kokubo; Yufeng Tong; Linda Z Penn; Maria Sunnerhagen
Journal:  Nat Struct Mol Biol       Date:  2019-11-04       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.